Applied Genetic Technologies Corporation NASDAQ:AGTC headquartered in Alachua, Florida, United States is reporting their earnings on 09/10/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.23.
According to stock market daily analyst this is Lower then same time previous year. Applied Genetic Technologies Corporation, reported EPS for the same quarter last year was $-0.18.
Overview of Applied Genetic Technologies Corporation NASDAQ:AGTC
The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida.
The company focuses on ophthalmologic genetic diseases. The company’s technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa,and age-related macular degeneration.The company has six products in various stages of development; as of 2016, none had yet been approved.
|% Change from 52 Week Low|
|% Change from 52 Week High|
Post Views: 59